Nicotine Replacement to Aid Smoking Cessation

Overview

About this study

The purpose of this study is to evaluate the effect of providing free, onsite nicotine replacement therapy to known tobacco users on long-term abstinence rates.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Active smoker or chewing tobacco user  

Exclusion Criteria: 

  • Age < 18 years
  • Pregnancy

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 09/09/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathaniel Miller, M.D.

Contact us for the latest status

Contact information:

Renee Weatherly

(507) 266-4680

weatherly.renee@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20582615

Mayo Clinic Footer